Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Russell Lipford

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Nature Cell Biology|October 3, 2003
Diverse roles for ubiquitin-dependent proteolysis in transcriptional activationJ Russell Lipford, Raymond J Deshaies
Nature Chemical Biology|August 5, 2020
Prospecting for molecular gluesWillem den Besten, J Russell Lipford
Nature|November 4, 2005
A putative stimulatory role for activator turnover in gene expressionJ Russell Lipford, Geoffrey T Smith, Yong Chi, et al.
Nature|October 9, 2009
Gal4 turnover and transcription activationGalen A Collins, J Russell Lipford, Raymond J Deshaies, et al.
Molecular & Cellular Proteomics : MCP|February 9, 2005
Analysis of polyubiquitin conjugates reveals that the Rpn10 substrate receptor contributes to the turnover of multiple proteasome targetsThibault Mayor, J Russell Lipford, Johannes Graumann, et al.
NPJ Vaccines|December 10, 2020
A nanoparticle vaccine that targets neoantigen peptides to lymphoid tissues elicits robust antitumor T cell responsesCarlos A Arbelaez, Juan Estrada, Melissa A Gessner, et al.
Journal of Medicinal Chemistry|April 6, 2017
A "Click Chemistry Platform" for the Rapid Synthesis of Bispecific Molecules for Inducing Protein DegradationRyan P Wurz, Ken Dellamaggiore, Hannah Dou, et al.
Toxicology and Applied Pharmacology|May 18, 2021
Mercapturate pathway metabolites of sotorasib, a covalent inhibitor of KRAS<sup>G12C</sup>, are associated with renal toxicity in the Sprague Dawley ratJonathan A Werner, Rhian Davies, Jan Wahlstrom, et al.
ACS Medicinal Chemistry Letters|January 16, 2015
Unfolded Protein Response in Cancer: IRE1α Inhibition by Selective Kinase Ligands Does Not Impair Tumor Cell ViabilityPaul E Harrington, Kaustav Biswas, David Malwitz, et al.
Science Advances|June 23, 2023
Quantitative measurement of the requirement of diverse protein degradation pathways in MHC class I peptide presentationJennifer L Mamrosh, David J Sherman, Joseph R Cohen, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Nature Cell Biology|October 3, 2003
Diverse roles for ubiquitin-dependent proteolysis in transcriptional activationJ Russell Lipford, Raymond J Deshaies
Nature Chemical Biology|August 5, 2020
Prospecting for molecular gluesWillem den Besten, J Russell Lipford
Nature|November 4, 2005
A putative stimulatory role for activator turnover in gene expressionJ Russell Lipford, Geoffrey T Smith, Yong Chi, et al.
Nature|October 9, 2009
Gal4 turnover and transcription activationGalen A Collins, J Russell Lipford, Raymond J Deshaies, et al.
Molecular & Cellular Proteomics : MCP|February 9, 2005
Analysis of polyubiquitin conjugates reveals that the Rpn10 substrate receptor contributes to the turnover of multiple proteasome targetsThibault Mayor, J Russell Lipford, Johannes Graumann, et al.
NPJ Vaccines|December 10, 2020
A nanoparticle vaccine that targets neoantigen peptides to lymphoid tissues elicits robust antitumor T cell responsesCarlos A Arbelaez, Juan Estrada, Melissa A Gessner, et al.
Journal of Medicinal Chemistry|April 6, 2017
A "Click Chemistry Platform" for the Rapid Synthesis of Bispecific Molecules for Inducing Protein DegradationRyan P Wurz, Ken Dellamaggiore, Hannah Dou, et al.
Toxicology and Applied Pharmacology|May 18, 2021
Mercapturate pathway metabolites of sotorasib, a covalent inhibitor of KRAS<sup>G12C</sup>, are associated with renal toxicity in the Sprague Dawley ratJonathan A Werner, Rhian Davies, Jan Wahlstrom, et al.
ACS Medicinal Chemistry Letters|January 16, 2015
Unfolded Protein Response in Cancer: IRE1α Inhibition by Selective Kinase Ligands Does Not Impair Tumor Cell ViabilityPaul E Harrington, Kaustav Biswas, David Malwitz, et al.
Science Advances|June 23, 2023
Quantitative measurement of the requirement of diverse protein degradation pathways in MHC class I peptide presentationJennifer L Mamrosh, David J Sherman, Joseph R Cohen, et al.
Pageof 3